What Neuberg Diagnostics does

Neuberg Diagnostics operates a multi-channel clinical laboratory and diagnostic services platform headquartered in Chennai, India, with a network spanning 250+ lab networks and 10,000+ touchpoints across 250+ Indian cities and 5,500+ pincodes, plus international operations in the UAE, South Africa, and the USA. Founded in 2015 by Dr. G.S.K. Velu as part of an International Diagnostics Alliance, the company offers 6,000+ pathological investigations spanning genomics, metabolomics, proteomics, biochemistry, microbiology, hematology, histopathology, molecular biology, and oncopathology, supported by 200+ in-house pathologists and reference laboratories in Bangalore, Ahmedabad, and Durban with CAP and NABL accreditation. In 2024 it launched the Geniee personalized genomics platform (wellness, pharmacogenomics, and screening for 2,300+ genetic conditions), and in 2026 it deployed a multi-agent AI system for Sigma-metrics quality control that reduces processing time from 15 days to under 60 minutes across ~130 assays.

The company serves three distinct customer segments: individual consumers (direct-to-consumer tests and packages booked online, via app, or through home sample collection), corporate clients (recurring wellness subscriptions covering pre-employment, annual, and executive health checks across banking, IT/ITES, manufacturing, FMCG, PSU, automotive, education, and travel sectors), and hospital/healthcare facilities (managed hospital lab outsourcing covering infrastructure, IT integration, and accreditation). Pricing for individual tests ranges from Rs. 85 to Rs. 1,690 and bundled health packages from Rs. 865 to Rs. 34,999, with genetic testing reaching Rs. 35,000 on the Geniee Platinum tier; a Rs. 999 monthly Doctor's Care Card subscription adds a recurring layer. Reported scale is 30+ million tests processed annually with public discounting of 29%–74% off listed menu prices.

The revenue base is projected by management at Rs. 16 billion for FY2026E and Rs. 20 billion for FY2027, with the company valued at approximately $547 million as of December 2025 following pre-IPO investments of Rs. 1,300 crore from Quadria Capital (2023) and Rs. 940 crore from Kotak Strategic Situations India Fund II (January 2025). A public listing is targeted for 2026 at a raise size of approximately $350 million, with proceeds and existing capital directed toward expansion, M&A, and personalized-medicine capability buildout.

Name

Neuberg Diagnostics

Legal name

Neuberg Diagnostics Private Limited

Website

http://www.neubergdiagnostics.com/

Company type

Private

Founded year

1938

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Neuberg Diagnostics is an Indian clinical laboratory chain offering 6,000+ pathology and genomic tests through 250+ lab networks and 10,000+ touchpoints. Founded in 2015 by Dr. G.S.K. Velu, it processes 30+ million tests annually across consumers, corporates, and hospitals.

Ownership category

akta.pro rank

Product category

Diagnostic Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Reference & Esoteric Testing Laboratories (HLAFAMAJ)

akta.pro secondary industries

Genetic & Prenatal Testing Laboratories (HLAFAMAH), Molecular Diagnostics (PCR/NAAT/NGS-based IVD) (HLAHAAAD)

Keywords

• Diagnostic services
• Clinical laboratory
• Pathology testing
• Genomic testing
• Corporate wellness

Headquarters

HQ city

Chennai

HQ country

India

HQ region

Asia

Offices6 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Supply Chain

Revenue model

1. Clinical Laboratory Testing Services: Core revenue from pathology and radiology diagnostic testing services. Individual tests range from Rs. 85 to Rs. 1,690, with health packages from Rs. 865 to Rs. 34,999. Revenue also generated from specialized tests including genetics and genomics.
2. Corporate Wellness Programs: B2B services offering comprehensive health packages for corporate employees including pre-employment checks, annual health checks, executive health checks, and on-site health camps across industries.
3. Hospital Lab Management: Managed services for hospital laboratories including infrastructure upgrade, IT integration, quality accreditation (NABL/ISO/CAP), and process optimization.

Pricing tiers

Go-to-market motion1 record

Distribution channels5 records

Marketing channels5 records

Core offering

Neuberg Diagnostics operates clinical laboratory and diagnostic testing services across India, UAE, South Africa, and the USA, offering over 6,000 varieties of pathological investigations including routine pathology, biochemistry, microbiology, hematology, histopathology, molecular biology, oncopathology, and personalized genomics. The company provides direct-to-consumer testing through 250+ lab networks, home sample collection, and digital report delivery, alongside B2B hospital lab management and corporate wellness programs.

Product overview

Neuberg Diagnostics is a multi-channel diagnostic services platform operating as a unified brand across pathology, radiology, and genomics. The core platform offers 6,000+ pathology tests and radiology imaging (X-ray, MRI, ultrasound, CT scan) through 250+ lab networks in India, UAE, South Africa, and the USA, accessible via web portal, mobile app, and home sample collection. The GENIEE sub-brand provides three tiers of personalized genomics products (Platinum, Wellness, Drug Response) which integrate genetic screening with the core diagnostic testing menu. Doctor First is a public health initiative built into the platform to drive appropriate clinical engagement. Corporate Wellness and Hospital Lab Management are B2B add-on modules that extend the core platform to enterprise clients and healthcare institutions.

Differentiator

Problem solved

Functional benefit

Brands

• Geniee: Personalized genomics platform offering wellness genomics, pharmacogenomics, and genetic health screening. Covers 59 genetic traits for nutrition, fitness, and disease susceptibility; personalized medication response for 170 drugs; and comprehensive risk assessment for 2,300+ genetic conditions.

Products and services

• Clinical Laboratory Testing Core clinical laboratory testing services including routine pathology, biochemistry, microbiology, hematology, and specialized tests. Tests range from Rs. 85 (Glucose-Fasting) to Rs. 1,690 (25 OH Cholecalciferol). Over 6,000 varieties of pathological investigations are offered across 250+ lab networks in India, with home sample collection and online report delivery. Targets individual patients seeking diagnostic tests.
• Health Check-up Packages Pre-bundled health check-up packages combining multiple tests at discounted prices, ranging from Rs. 865 (Diabetes Care Basic, 7 tests) to Rs. 34,999 (Geniee Wellness Super Premium). Includes packages like Her Essential Basic (79 tests at Rs. 2,199), Master Health Checkup (105 tests at Rs. 6,480), and Annual Health Checkup variants. Targets individual consumers seeking preventive health screenings.
• GENIEE Personalized Genomics Platform Personalized genomics sub-brand offering genetic screening across three tiers: GENIEE Platinum (Rs. 35,000, covering wellness genomics, pharmacogenomics for 170+ drugs, and health screening for 2,300+ conditions), GENIEE Wellness (Rs. 22,000, covering 59 wellness traits and pharmacogenomics), and Drug Response tiers. Provides insights on nutrition, fitness, medication response, and hereditary disease risks. Targets health-conscious individual consumers and patients.
• Corporate Wellness Program B2B corporate wellness services offering comprehensive health packages for corporate employees including pre-employment checks, annual health checks, executive health checks, on-site health camps, and insurance medical checks across banking, IT/ITES, manufacturing, FMCG, PSU, automotive, education, and travel sectors. Targets HR heads and corporate wellness managers.
• Hospital Lab Management Services Managed services for hospital laboratories including infrastructure upgrade, IT integration with hospital LIS systems, staff training, quality and accreditation support (NABL/ISO/CAP), process optimization, and business development. Targets hospital administrators and healthcare facility operators.
• Home Sample Collection Home visit sample collection service allowing patients to book sample collection from their homes. Available across service areas with dedicated phone lines (89390 66655) and online booking through website and app. Targets individual consumers preferring at-home convenience.
• Doctor Care Card Subscription-based membership card for doctors and their families offering 30% off on routine blood tests, free home sample collection, and access to Dr Care Package at Rs. 999 covering Liver Function Test, Kidney function test, CBC, HbA1c, and Vitamin D. Targets medical professionals and their families.

Quantifiable outcome

• Reduced Sigma metrics computation from 15 days to under 60 minutes for 130 assays through agentic AI implementation
• +2 more outcomes

Named customers1 record

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability3 records

Feature3 records

Partnerships

Five partnerships are on record, tiered core and minor.

• bioMerieuxcoreStrategic or Co-development Partner · 18 July 2024bioMerieux collaborated on Pre-Conference Workshop on Sepsis Solutions at PathFinders 2024. Dr. Debkishore Gupta (Director and Head, Medical Affairs, bioMerieux South Asia) and Dr. Devjani De (Lead, Medical Affairs, bioMerieux South Asia) served as workshop faculty covering antimicrobial interpretation, sepsis diagnostics, and syndromic approach.
• IAPM (Indian Association of Pathologists and Microbiologists) - Tamil Nadu ChaptercoreStrategic or Co-development PartnerPathFinders 2024 conference organized under the aegis of TamilNadu and Pondicherry Chapter of IAPM - TNCIAPM, focused on 'Integrated Diagnostics: Trends Defining the Future of Diagnostic Medicine'.
• ITC Grand Chola ChennaiminorOthersConference venue partner for PathFinders 2024 conference held on July 20-21, 2024.
• Labsystems Diagnostics Oy (Finland)minorStrategic or Co-development PartnerDr. Kumar Shubham (Associate Vice President, Labsystems Diagnostics Oy, Finland) contributed to Pre-Conference Workshop on Newborn Screening Solutions at PathFinders 2024.
• Trivitron HealthcarecoreStrategic or Co-development PartnerDr. Santosh Devraj Pradhan (Assistant Product Manager, Trivitron Healthcare, India) contributed to Newborn Screening Workshop. GSK Velu is also preparing Trivitron Healthcare for public listing.

Scale indicators11 records

Recent moves10 records

Expansion highlights6 records

Direct peers

• Dr. Lal PathLabs: India's largest diagnostic chain by revenue and network. Directly comparable in clinical lab services, B2B hospital partnerships, and home sample collection; Neuberg is positioned as the #4 challenger to Dr. Lal's #1 incumbency.
• Metropolis Healthcare: Listed Indian diagnostic chain with comparable B2B hospital lab management, corporate wellness, and specialty testing offerings. Competes head-to-head in metros and offers a directly comparable public-market benchmark for Neuberg's pre-IPO valuation.
• Agilus Diagnostics (formerly SRL Diagnostics): Pan-India diagnostic chain owned by Fortis Healthcare. Overlaps with Neuberg across pathology, reference lab services, hospital partnerships, and corporate wellness — one of the top three players against which Neuberg directly competes.
• Thyrocare Technologies: Volume-focused diagnostic network acquired by PharmEasy. Directly comparable in low-cost preventive health packages and pan-India B2B2C distribution; competes with Neuberg on package pricing strategy.
• Apollo Diagnostics: Diagnostic arm of Apollo Hospitals. Directly comparable in hospital-affiliated lab services, preventive health packages, and home sample collection across India, leveraging Apollo's hospital referral network.

Emerging players

• Pathkind Labs: India-based diagnostic chain expanding aggressively in North and East India. Comparable in B2B hospital lab management and preventive packages; smaller than Neuberg but pursuing similar pan-India consolidation strategy.
• Healthians: Digital-first Indian diagnostic platform with strong home-sample-collection flywheel. Competes with Neuberg on tech-led DTC booking and at-home preventive packages but lacks reference-lab depth and B2B hospital presence.
• Tata 1mg Labs: Digital health platform backed by Tata Group offering diagnostic booking. Partially overlaps with Neuberg's DTC booking and home-collection but operates a marketplace model rather than owned labs at Neuberg's scale.

Regional players

• Suburban Diagnostics: Strong regional diagnostic chain in Western and Central India. Overlaps with Neuberg on B2C pathology, corporate wellness, and home collection but with limited national or international footprint versus Neuberg's 250+ city network.

Others

• Trivitron Healthcare: Medical technology and IVD company also founded by GSK Velu and slated for IPO. Not a direct competitor but is a sister company and ecosystem participant — provides IVD equipment and reagents, with overlapping newborn screening collaboration at PathFinders 2024.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat7 records

Key risks6 records

Key highlights7 records

Customer concentration

• Instagraminstagram.com/neubergdiagnostics/?hl=en

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries1 record

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Neuberg Diagnostics